Munafò, A.; Arillotta, D.; Mannaioni, G.; Schifano, F.; Bernardini, R.; Cantarella, G.
Psilocybin for Depression: From Credibility to Feasibility, What’s Missing? Pharmaceuticals 2023, 16, 68.
https://doi.org/10.3390/ph16010068
AMA Style
Munafò A, Arillotta D, Mannaioni G, Schifano F, Bernardini R, Cantarella G.
Psilocybin for Depression: From Credibility to Feasibility, What’s Missing? Pharmaceuticals. 2023; 16(1):68.
https://doi.org/10.3390/ph16010068
Chicago/Turabian Style
Munafò, Antonio, Davide Arillotta, Guido Mannaioni, Fabrizio Schifano, Renato Bernardini, and Giuseppina Cantarella.
2023. "Psilocybin for Depression: From Credibility to Feasibility, What’s Missing?" Pharmaceuticals 16, no. 1: 68.
https://doi.org/10.3390/ph16010068
APA Style
Munafò, A., Arillotta, D., Mannaioni, G., Schifano, F., Bernardini, R., & Cantarella, G.
(2023). Psilocybin for Depression: From Credibility to Feasibility, What’s Missing? Pharmaceuticals, 16(1), 68.
https://doi.org/10.3390/ph16010068